Colonoscopy Trial Highlights Strengths, Weaknesses in Benefits
Updated findings from a European randomized trial continued to show that colonoscopy screening significantly reduced colorectal cancer (CRC) incidence, but its impact on CRC mortality was less clear. At 13 years of follow-up, the incidence of CRC was 1.46% among participants who underwent colonoscopy screening versus 1.80% in the no-screening group, with a risk ratio…
